Kenneth I Berger

6PUBLICATIONS
0CO-AUTHORS
Rehabilitation engineeringPacific Peoples life courseEpidemiological modellingMicrobial ecology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 13, 2025
Efficacy of Switching Therapy From Alglucosidase Alfa to Avalglucosidase Alfa on Respiratory Function in Participants With Late-Onset Pompe Disease: A Post Hoc Analysis From the COMET Trial.

Priya S Kishnani, Matthias Boentert, Stephan Wenninger

|Jun 19, 2024
Changes in forced vital capacity over ≤ 13 years among patients with late-onset Pompe disease treated with alglucosidase alfa: new modeling of real-world data from the Pompe Registry.

Kenneth I Berger, Yin-Hsiu Chien, Alberto Dubrovsky

|Jun 13, 2019
Forced vital capacity and cross-domain late-onset Pompe disease outcomes: an individual patient-level data meta-analysis.

Kenneth I Berger, Steve Kanters, Jeroen P Jansen

|Feb 21, 2018
Small Airway Disease Syndromes. Piercing the Quiet Zone.

Kenneth I Berger

Pageof 1

Frequent Collaborators